Not available
Quote | Arbutus Biopharma Corporation (NASDAQ:ABUS)
Last: | $2.69 |
---|---|
Change Percent: | -3.24% |
Open: | $2.78 |
Close: | $2.78 |
High: | $2.8 |
Low: | $2.69 |
Volume: | 521,494 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Arbutus Biopharma Corporation (NASDAQ:ABUS)
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it...
2024-04-10 04:22:17 ET Summary Arbutus Biopharma and Roivant won a crucial claims construction ruling in their patent infringement lawsuit against Moderna. The ruling opens the way for a potential total win against Moderna, but uncertainties remain regarding the lawsuit and Arbutu...
Message Board Posts | Arbutus Biopharma Corporation (NASDAQ:ABUS)
Subject | By | Source | When |
---|---|---|---|
$ABUS Arbutus Biopharma Corporation | mick | investorshub | 04/30/2023 11:03:50 PM |
Arbutus Biopharma Corporation (Nasdaq: $ABUS), a clinical-stage biopharmaceutical | mick | investorshub | 04/18/2023 8:07:45 PM |
With a median price-to-sales (or "P/S") ratio of | mick | investorshub | 04/18/2023 8:06:48 PM |
$ABUS Arbutus Biopharma Corporation | mick | investorshub | 04/15/2023 6:42:52 PM |
rare form / https://investorshub.advfn.com/Arbutus-Biopharma-Corporation-17838#: | mick | investorshub | 04/15/2023 6:42:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Arbutus Biopharma Corporation Company Name:
ABUS Stock Symbol:
NASDAQ Market:
Arbutus Biopharma Corporation Website:
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company leve...
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it...